Ticker: SAP

SAP

Software Technology Software - Application
Price 238.14
Reco Buy Potential 76 Risk 36 Updated 2026-10-24

Forecast impact

positive
Target +20.9% target fill 82.7%
Reaction D5 pending · D10 pending fresh confirmed · market trust
Impact Potential +6 · Risk -3 valid until 2026-11-22

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

SAP is a global leader in enterprise software, specializing in solutions that enhance business operations and data management. Its core products include ERP software, cloud solutions, and analytics tools. Major business segments encompass cloud services, software licenses, and support services, with primary revenue sources derived from subscription fees and software sales. The company serves various industries, including finance, healthcare, and manufacturing, facilitating digital transformation for its clients.

Investment Profile

The investment profile of SAP is more aligned with value investors, given its stable dividend yield and established market presence. The stock may appeal to those seeking moderate growth potential, though recent revenue trends indicate some challenges. Investors should consider the company's volatility and risk factors when assessing suitability.

Fundamental metrics (experimental) Updated: 2026-10-21
EPS (TTM) — earnings per share for the last 12 months, $
6.85
Revenue QoQ — quarter-over-quarter revenue growth
3.4%
EPS surprise
-7.5%
20d volatility
0.9%
Dividend yield
1.3%
last ex-date
2026-05-05
AI recommendation changes
Date Before After Reason
2026-10-09 Hold Buy Mixed signals; positive momentum but EPS surprise concerns.
2026-09-24 Buy Hold Mixed momentum; fundamentals show some weakness.
2026-09-16 Hold Buy Mixed performance; cautious due to EPS surprise.
Analyst forecasts
Date Analyst Action Target Price Then
2026-10-23 Barclays Target Raised 243 → 288 240.59
2026-10-22 D.A. Davidson Target Raised — → 800 242.45
2026-10-13 Barclays Target Raised 242 → 243 217.85
News Page 1 of 1
Forte Biosciences Rivian Exxon Mobil SAP ASML Amkor Technology Baker Hughes Chevron

Stocks Making Significant Moves Midday: ASML, SK Hynix, SAP, Forte Biosciences, and More

Several companies experienced significant stock movements, with ASML declining due to competition from Chinese chipmakers, while Forte Biosciences surged following an acquisition announcement. These developments highlight the ongoing volatility in the semiconductor and biotech sectors, which could impact investor sentiment and market dynamics.
Tenet Healthcare Robert Half MaxLinear SAP Amkor Technology Oracle Nvidia Deckers Outdoor American Express Intel

Stocks Making Significant Moves Premarket: Intel, Oracle, American Express, and More

Premarket trading saw significant movements in various companies, with Intel and Oracle experiencing notable gains due to strong earnings and strategic agreements, while others like Robert Half and MaxLinear faced declines despite reporting better-than-expected results.